Tom Baker Cancer Centre /ID# 276206

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Colorectal cancer
• Gastric and oesophageal cancer
• Head and neck cancer
• Lung cancer
• Ovarian cancer
• Pancreatic cancer
• Triple-negative breast cancer

Running trials

• Recruiting

  Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

  NCT05005403· Phase 1· AbbVie· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Head and neck cancer1 recruiting
• Lung cancer1 recruiting
• Ovarian cancer1 recruiting
• Pancreatic cancer1 recruiting
• Triple-negative breast cancer1 recruiting